… with transcutaneouspatches of arrayed microneedles (MNs), researchers has focused on the development of bioresponsivepatches … several bioresponsivetransdermal MN-patches for …
… on diabetic rats by the transdermal delivery is illustrated. … immunotherapy through a transdermal MN vaccine patch. The … Table 2 summarizes representative bioresponsive MNs and …
… Herein, we will summarize and classify recent advances in the development of bioresponsive transcutaneouspatches, including pH-responsive, glucose-responsive, and enzyme-…
… transcutaneouspatch could sense the thrombin levels in capillary blood circulation, and there was little drug leaked from the patch … that this bioresponsivepatch could effectively prevent …
A McConville, J Atchison, A Roddy, J Davis - Sensors and Actuators B …, 2019 - Elsevier
… physical removal of the patch. The evolution of transdermalpatches towards smarter, stimuli … , electrical activation, light initiation and bioresponsive systems coming to the fore. These …
… Microneedle (MN) arrays are needles of 25 μm–2000 μm supported on a base or patch [52], it was first conceptualized as a non-invasive parenteral (transdermal) drug delivery system …
J He, Y Zhang, X Yu, C Xu - Acta pharmaceutica sinica B, 2023 - Elsevier
… development of wearable patch for transdermal drug delivery. These patches are grouped … Some of these bioresponsive MNs for insulin delivery have been seen in clinical trials 9 , 62 …
… Here, we show that a single removable transdermalpatch, bearing microneedles loaded with insulin and a non-degradable glucose-responsive polymeric matrix, and fabricated via in …